Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been given a consensus rating of “Moderate Buy” by the eight ratings firms that are currently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $56.31.

Several research analysts have recently issued reports on the stock. KeyCorp cut their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, March 3rd. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $43.00 to $35.00 in a research report on Friday, February 28th. Royal Bank of Canada cut their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Bank of America lowered their price target on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Finally, StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently made changes to their positions in ACHC. Phocas Financial Corp. lifted its position in Acadia Healthcare by 30.6% during the fourth quarter. Phocas Financial Corp. now owns 94,320 shares of the company’s stock valued at $3,740,000 after buying an additional 22,095 shares during the period. Public Employees Retirement System of Ohio purchased a new position in Acadia Healthcare during the 4th quarter valued at about $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Acadia Healthcare by 22.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company’s stock worth $12,439,000 after acquiring an additional 56,647 shares in the last quarter. Voloridge Investment Management LLC purchased a new stake in Acadia Healthcare in the fourth quarter worth about $15,770,000. Finally, Squarepoint Ops LLC bought a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $1,087,000.

Acadia Healthcare Trading Down 1.0 %

Shares of ACHC stock opened at $29.14 on Wednesday. The business has a 50-day moving average of $39.52 and a 200 day moving average of $47.57. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a 1-year low of $27.61 and a 1-year high of $82.41. The stock has a market capitalization of $2.71 billion, a PE ratio of 9.55, a P/E/G ratio of 1.46 and a beta of 1.38.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.